JADPRO

The Journal of the Advanced Practitioner in Oncology is the first journal developed by and for oncology advanced practitioners.

[JADPRO @JADPRO]

In this editorial, Editor-in-Chief Beth Faiman explores how advanced practitioners can thoughtfully integrate AI tools into clinical documentation, research, and scholarly communication while navigating important ethical and clinical considerations.
https://t.co/1IfaoAKZpZ

[JADPRO @JADPRO]

Advanced practitioners, share your work with your peers by submitting an abstract to #JADPROLive! Present innovative, original work that is significant to the role of the advanced practitioner in oncology and hematology.
Learn more: https://t.co/BtNgoRbGuW

[JADPRO @JADPRO]

Amber Koehler, MPAS, PA-C, of Mayo Clinic and this year’s Conference Chair, shares why JADPRO Live is the premier meeting for oncology APs: a place to learn, collaborate, and support one another while advancing patient care.
Minneapolis | Oct. 15–18
https://t.co/aReufAUlnI

[JADPRO @JADPRO]

🚨 Last call to register!
Join this live webinar with Karolina Faysman, MSN, AOCNP, DNP(c), as she explores case-based strategies for monitoring and managing patients on menin inhibitors, with a focus on NPM1-mutated AML. https://t.co/XKt0h44JQ7

[JADPRO @JADPRO]

Emerging data suggest that carefully selected patients may benefit from quadruplet therapy, reinforcing the need for personalized approaches that balance efficacy, tolerability, and quality of life.
Learn more: https://t.co/Ufg0vgYoIx

[JADPRO @JADPRO]

🚨 Join this live webinar with Karolina Faysman, MSN, AOCNP, DNP(c), as she explores case-based strategies for monitoring and managing patients on menin inhibitors, with a focus on NPM1-mutated AML.
📅 May 20 | 6–7 PM EDT
💡Designed for APs
https://t.co/XKt0h44JQ7

[JADPRO @JADPRO]

The May/June issue of JADPRO is LIVE!
Discover ways to improve the quality of care for patients with cancer, support critical issues in advanced practice in oncology and recognize the expanding contributions of advanced practitioners in oncology.
https://t.co/NceknrJtbX

[JADPRO @JADPRO]

Step into real-world oncology decision-making.
JADPRO’s Clinical Case Series brings together case-based learning and expert-led insights. Review patient cases, answer key questions, and deepen your understanding through an on-demand webinar.
Learn more: https://t.co/moC4JqzQ5a

[JADPRO @JADPRO]

🎉JADPRO Live registration is now open!

Join advanced practitioners from across the country to learn about the latest innovations in oncology from October 15–18 in Minneapolis.

Secure Your Spot: https://t.co/ft7EYqRDvX

[JADPRO @JADPRO]

Cancer treatment during pregnancy presents complex clinical decisions that require a multidisciplinary approach.

Learn more about the clinical considerations surrounding CRC diagnosis and treatment in pregnancy: https://t.co/ti4nrCJ3dx

[JADPRO @JADPRO]

Join this live webinar with Karolina Faysman, MSN, AOCNP, DNP(c), as she explores case-based strategies for monitoring and managing patients on menin inhibitors, with a focus on NPM1-mutated AML.
📅 May 20 | 6–7 PM EDT
💡Designed for APs
Register today: https://t.co/XKt0h44JQ7

[JADPRO @JADPRO]

Patients with gliomas face unique physical, neurologic, and psychosocial challenges throughout their care journey.
New findings reinforce the value of timely specialized palliative care and multidisciplinary support for both patients and caregivers: https://t.co/98nyfw0Sc7

[JADPRO @JADPRO]

Join JADPRO Live, the premier CE-accredited event for advanced practitioners on October 15–18 in Minneapolis!
Learn from experts, connect with your peers, and gain insights that you can bring back to your practice.
👉 Register today: https://t.co/ft7EYqRDvX

[JADPRO @JADPRO]

Survivorship care is more than surveillance.

A recent QI project demonstrates that routine distress screening in head and neck cancer survivors can significantly increase appropriate psychosocial referrals, addressing an often-overlooked aspect of care: https://t.co/xsgRlczhQD

[JADPRO @JADPRO]

Looking to deepen your knowledge in multiple myeloma management?
Discover tools, clinical updates, and expert perspectives designed to support advanced practitioners in delivering high-quality, patient-centered care.
https://t.co/RTLVtHG7CD

[JADPRO @JADPRO]

Advanced practitioners, share your work with your peers by submitting an abstract to #JADPROLive! Present innovative, original work that is significant to the role of the advanced practitioner in oncology and hematology. The deadline to submit is July 1.
https://t.co/BtNgoRbGuW

[JADPRO @JADPRO]

In this case-based discussion, Amy Goodrich, RN, BSN, MSN, CRNP-AC, Jill Miller, MS, PA-C, and Mollie Moran, APRN-CNP, review management strategies for a patient with TP53 mutation and del(17p), highlighting the role of BTK inhibitor monotherapy. https://t.co/xf4e2SwAFY

[JADPRO @JADPRO]

What’s next for MGUS?
Ongoing research focuses on refining monitoring guidelines, identifying high-risk patients earlier, and developing preventive strategies to reduce progression to malignancy.
Learn more: https://t.co/A5KLMg3L11
#OncologyResearch #MultipleMyeloma

[JADPRO @JADPRO]

CAR T-cell therapy is transforming outcomes in hematologic malignancies, and advanced practitioners play a critical role in care delivery.
Access curated resources, real-world case insights, and expert guidance to support your clinical decision-making.
https://t.co/iQiyL92XmI

[JADPRO @JADPRO]

🎉 JADPRO Live registration is officially OPEN!

Join us October 15–18 in Minneapolis for the premier CE-accredited conference, bringing together a community of advanced practitioners dedicated to advancing cancer care.

Register today: https://t.co/ft7EYqRDvX